FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET

PURPOSE: Define the safety and effectiveness of T-cells re-directed against Follicle-Stimulating Hormone Receptor (FSHR)-expressing ovarian cancer cells. EXPERIMENTAL DESIGN: FSHR expression was determined by Western-blot, immunohistochemistry and Q-PCR in 77 human ovarian cancer specimens from 6 di...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Perales-Puchalt, Alfredo, Svoronos, Nikolaos, Rutkowski, Melanie R, Allegrezza, Michael J, Tesone, Amelia J, Payne, Kyle K, Wickramasinghe, Jayamanna, Nguyen, Jenny M, O'Brien, Shane W, Gumireddy, Kiranmai, Huang, Qihong, Cadungog, Mark G., Connolly, Denise C, Tchou, Julia, Curiel, Tyler J, Conejo-Garcia, Jose R.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241180/
https://ncbi.nlm.nih.gov/pubmed/27435394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars